oseltamivir has been researched along with Sensitivity and Specificity in 48 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (2.08) | 18.2507 |
| 2000's | 14 (29.17) | 29.6817 |
| 2010's | 33 (68.75) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cárdenas, AM; Chang, YC; Feemster, K; Mitchell, SL | 1 |
| Eom, G; Guk, K; Ha, K; Hwang, SG; Jung, J; Kang, T; Lee, DK; Lim, EK; Park, H; Song, S | 1 |
| Anber, J; Boucher, C; Maaskant, J; Osterhaus, A; Rimmelzwaan, G; Schutten, M; Stadhouders, R; van Beek, R; van der Linden, A; van der Vries, E; Wu, Y | 1 |
| Boucher, BA; Herring, VL; Hickerson, WL; Hu, ZY; Laizure, SC; Parker, RB | 1 |
| Bumpenkiatigul, N; Sritipsukho, P; Tangsathapornpong, A | 1 |
| de Briel, D; Heller, R; Martin, A; Martinot, M; Mohseni-Zadeh, M; Mothes, A; Sagot, E; Souply, L | 1 |
| Joo, KW; Kim, DK; Kim, M; Kim, S; Kim, YS; Lee, JP; Lee, JW; Lim, CS; Oh, KH; Shin, KH; Yu, KS | 1 |
| Chandler, DP; Golova, JB; Griesemer, SB; Knickerbocker, C; Lambarqui, A; Perov, AN; Rudy, GB; St George, K; Wiles, C; Zimmerman, C | 1 |
| Boivin, G; Carbonneau, J; Shelton, DN; Taylor, SC | 1 |
| Bushell, CA; Cowen, S; Foy, CA; Garson, JA; Grant, PR; Gutierrez-Aguirre, I; Huggett, JF; Milavec, M; Nastouli, E; O'Sullivan, DM; Whale, AS; Žel, J | 1 |
| Shen, K; Tan, SC; Wu, J; Xiong, T | 1 |
| Abed, Y; Boivin, G; Carbonneau, J; Kaiser, L; L'Huillier, AG | 1 |
| Busson, L; De Foor, M; Hallin, M; Mahadeb, B; Vandenberg, O | 1 |
| Carr, MJ; Connell, J; Duffy, M; Hall, WW; Sayre, N | 1 |
| Balish, A; Bright, RA; Deyde, VM; Gubareva, LV; Klimov, AI; Lindstrom, S; Nguyen, T; Shu, B | 1 |
| Bolotin, S; Burton, L; Chong-King, E; De Lima, C; Drews, SJ; Eshaghi, A; Lombos, E; Mazzulli, T; Robertson, AV | 1 |
| Hayashi, Y; Ishii, F; Iwaki, K; Kobari, T; Nagashima, T; Yajima, T | 1 |
| Gu, Y; Kamiya, H; Komiya, N; Matsui, T; Okabe, N; Yahata, Y; Yasui, Y | 1 |
| Aron, GI; Bestebroer, TM; Boucher, CA; Fouchier, RA; Guldemeester, J; Herfst, S; Jonges, M; Koopmans, M; Maaskant, J; Meijer, A; Osterhaus, AD; Schutten, M; Van der Linden, A; van der Vries, E | 1 |
| Deyde, VM; Garten, R; Gubareva, LV; Klimov, AI; Okomo-Adhiambo, M; Sheu, TG; Trujillo, AA | 1 |
| Agut, H; Boutolleau, D; Brun-Vezinet, F; Deback, C; Houhou, N | 1 |
| Perret P, C | 1 |
| Chan, PK; Hui, DS; Lam, WY; Lee, N; Leung, TF; Ngai, KL | 1 |
| Moser, MJ; Operario, DJ; St George, K | 1 |
| Corey, L; Kuypers, J; Renaud, C | 1 |
| Bhatt, PA; Bhavesh, D; Kanneti, R; Paramar, D; R, S | 1 |
| Bennett, S; Carman, WF; Gunson, RN; MacLean, A; Miller, R | 1 |
| Heikkinen, T; Heinonen, S; Lehtinen, P; Silvennoinen, H; Vainionpää, R | 1 |
| Baranovich, T; Caperig-Dapat, I; Dapat, C; Nishikawa, M; Saito, R; Sato, I; Suzuki, H; Suzuki, T; Suzuki, Y; Tamura, T; Zaraket, H | 1 |
| Drews, SJ; Fonseca, K; Pabbaraju, K; Wong, A; Wong, S | 1 |
| Barr, I; Caldwell, N; Chidlow, G; Deng, YM; Hurt, A; Kelso, A; Shaw, T; Smith, D; Williams, S | 1 |
| Chen, N; Lee, BP; Lin, M; Pinsky, BA; Schrijver, I | 1 |
| Makkoch, J; Payungporn, S; Poomipak, W; Poovorawan, Y; Rianthavorn, P; Theamboonlers, A | 1 |
| Koay, ES; Lee, CK; Lee, HK; Loh, TP; Tambyah, PA; Tang, JW | 1 |
| Aleemi, VE; Bao, JR; Clark, RB; Coon, SL; Huard, TK; Lewinski, MA; Master, RN; Piscitelli, AE; Tummala, PR | 1 |
| Aziz, M; Aziz, Z; Eltoukhy, N; Patel, S; Singh, K; Vasoo, S | 1 |
| Chang, LY; Huang, LM; Kao, CL; Lee, CY; Lee, PI; Lu, CY; Shao, PL; Tsou, TP; Yang, PC | 1 |
| Cen, S; He, Z; Li, XY; Liu, ZL; Wang, X; Wang, Z; Wei, XL; Yin, X; Zhang, ZZ; Zhou, JM | 1 |
| Clements, DA; Hamilton, JD; Huber, J; Lee, PY; Matchar, DB; Peterson, ED | 1 |
| Bellantonio, S; Rose, DN; Rothberg, MB | 1 |
| Elias, S; Herlocher, ML; Monto, AS; Ohmit, SE; Rotthoff, J; Teich, E; Truscon, R; Yen, HL | 1 |
| Amonsin, A; Chaisingh, A; Chieochansin, T; Chutinimitkul, S; Damrongwatanapokin, S; Landt, O; Mai, le Q; Poovorawan, Y; Songserm, T; Suwannakarn, K; Theamboonlers, A | 1 |
| Barr, CE; Bradley, JS; Iacuzio, D; Schulman, K | 1 |
| Bahrami, G; Kiani, A; Mohammadi, B | 1 |
| Cundy, KC; Eisenberg, EJ | 1 |
| Citron, A; Clarke, T; Gray, D; Herron, W; Serpe, C; Wiltshire, B; Wiltshire, H | 1 |
| Cross, J; Wedekind, CA | 1 |
3 trial(s) available for oseltamivir and Sensitivity and Specificity
| Article | Year |
|---|---|
Dose selection method for pharmacokinetic study in hemodialysis patients using a subpharmacological dose: oseltamivir as a model drug.
Topics: Computer Simulation; Dose-Response Relationship, Drug; Drug Monitoring; Drug Therapy, Computer-Assisted; Enzyme Inhibitors; Female; Humans; Kidney Diseases; Male; Middle Aged; Models, Biological; Oseltamivir; Renal Dialysis; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2014 |
Viral load and clinical features in children infected with seasonal influenza B in 2006/2007.
Topics: Abdominal Pain; Adolescent; Age Factors; Antiviral Agents; Child; Child, Preschool; Chills; Female; Fever; Humans; Infant; Influenza B virus; Influenza, Human; Male; Musculoskeletal Pain; Oseltamivir; Prospective Studies; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; Sensitivity and Specificity; Viral Load | 2012 |
Determination of oseltamivir carboxylic acid in human serum by solid phase extraction and high performance liquid chromatography with UV detection.
Topics: Adult; Antiviral Agents; Carboxylic Acids; Chromatography, High Pressure Liquid; Cross-Over Studies; Drug Stability; Enzyme Inhibitors; Humans; Male; Neuraminidase; Oseltamivir; Quality Control; Reproducibility of Results; Sensitivity and Specificity; Therapeutic Equivalency | 2008 |
45 other study(ies) available for oseltamivir and Sensitivity and Specificity
| Article | Year |
|---|---|
Implementation of a rapid influenza A/B and RSV direct molecular assay improves emergency department oseltamivir use in paediatric patients.
Topics: Antiviral Agents; Child; Child Health; Child, Preschool; Emergency Service, Hospital; Female; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Male; Molecular Diagnostic Techniques; Nasopharynx; Oseltamivir; Reagent Kits, Diagnostic; Real-Time Polymerase Chain Reaction; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Sensitivity and Specificity; Treatment Outcome; Virus Diseases | 2018 |
Rapid and simple detection of Tamiflu-resistant influenza virus: Development of oseltamivir derivative-based lateral flow biosensor for point-of-care (POC) diagnostics.
Topics: Antiviral Agents; Biosensing Techniques; Calorimetry; Diagnostic Tests, Routine; Drug Resistance, Viral; Humans; Influenza, Human; Microbial Sensitivity Tests; Orthomyxoviridae; Oseltamivir; Point-of-Care Systems; Sensitivity and Specificity | 2018 |
Molecular assays for quantitative and qualitative detection of influenza virus and oseltamivir resistance mutations.
Topics: Drug Resistance, Viral; Evaluation Studies as Topic; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza, Human; Mutation; Neuraminidase; Oseltamivir; Real-Time Polymerase Chain Reaction; RNA, Viral; Sensitivity and Specificity | 2013 |
Nonvolatile salt-free stabilizer for the quantification of polar imipenem and cilastatin in human plasma using hydrophilic interaction chromatography/quadrupole mass spectrometry with contamination sensitive off-axis electrospray.
Topics: Acetonitriles; Chromatography, Liquid; Cilastatin; Humans; Hydrophobic and Hydrophilic Interactions; Imipenem; Linear Models; Methanol; Oseltamivir; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization | 2013 |
Pandemic influenza (H1N1) 2009 of pediatric patients at Thammasat University Hospital.
Topics: Age Factors; Antiviral Agents; Child; Child, Preschool; Female; Hospitals, University; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Oseltamivir; Pandemics; Sensitivity and Specificity; Thailand | 2012 |
Contribution of systematic RT-PCR screening for influenza during the epidemic season.
Topics: Adult; Aged; Anti-Bacterial Agents; Antiviral Agents; Cross Infection; Delayed Diagnosis; Diagnosis, Differential; Disease Outbreaks; Emergency Service, Hospital; Female; Fever; France; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza B virus; Influenza, Human; Lung Diseases; Male; Middle Aged; Oseltamivir; Patients' Rooms; Reagent Kits, Diagnostic; Real-Time Polymerase Chain Reaction; Seasons; Sensitivity and Specificity | 2014 |
Development and clinical testing of a simple, low-density gel element array for influenza identification, subtyping, and H275Y detection.
Topics: Antiviral Agents; Drug Resistance, Viral; Humans; Influenza A Virus, H1N1 Subtype; Laboratories; Microarray Analysis; Molecular Diagnostic Techniques; Molecular Typing; Mutant Proteins; Nasopharynx; Neuraminidase; Oseltamivir; Retrospective Studies; Sensitivity and Specificity; Time Factors; Viral Proteins; Workforce | 2014 |
Optimization of Droplet Digital PCR from RNA and DNA extracts with direct comparison to RT-qPCR: Clinical implications for quantification of Oseltamivir-resistant subpopulations.
Topics: Antiviral Agents; Child, Preschool; Drug Resistance, Viral; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Neuraminidase; Oseltamivir; Polymerase Chain Reaction; Reproducibility of Results; Sensitivity and Specificity; Viral Load; Viral Proteins | 2015 |
Detection of Rare Drug Resistance Mutations by Digital PCR in a Human Influenza A Virus Model System and Clinical Samples.
Topics: Antiviral Agents; Drug Resistance, Viral; Genes, Viral; Humans; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza, Human; Molecular Typing; Mutation; Oseltamivir; Polymorphism, Single Nucleotide; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Sensitivity and Specificity | 2016 |
Oseltamivir Treatment for Children with Influenza-Like Illness in China: A Cost-Effectiveness Analysis.
Topics: Adolescent; Algorithms; Antiviral Agents; Child; Child, Preschool; China; Cost-Benefit Analysis; Decision Making; Health Care Costs; Humans; Infant; Infant, Newborn; Influenza, Human; Models, Economic; Oseltamivir; Probability; Quality-Adjusted Life Years; Sensitivity and Specificity | 2016 |
Droplet digital PCR to investigate quasi-species at codons 119 and 275 of the A(H1N1)pdm09 neuraminidase during zanamivir and oseltamivir therapies.
Topics: Antiviral Agents; Codon; Drug Resistance, Viral; Genetic Variation; Genotyping Techniques; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Microbial Sensitivity Tests; Middle Aged; Mutation, Missense; Neuraminidase; Oseltamivir; Polymerase Chain Reaction; Sensitivity and Specificity; Zanamivir | 2017 |
Contribution of a rapid influenza diagnostic test to manage hospitalized patients with suspected influenza.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Child; Child, Preschool; Diagnostic Tests, Routine; Disease Management; Female; Hospitalization; Humans; Infant; Infant, Newborn; Influenza A virus; Influenza B virus; Influenza, Human; Male; Middle Aged; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; Oseltamivir; Point-of-Care Systems; Reagent Kits, Diagnostic; Sensitivity and Specificity; Young Adult | 2017 |
Rapid molecular detection of the H275Y oseltamivir resistance gene mutation in circulating influenza A (H1N1) viruses.
Topics: Alleles; Amino Acid Substitution; Antiviral Agents; Drug Resistance, Viral; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Microbial Sensitivity Tests; Mutation; Neuraminidase; Oseltamivir; Reverse Transcriptase Polymerase Chain Reaction; Sensitivity and Specificity; Time Factors | 2008 |
Detection of molecular markers of antiviral resistance in influenza A (H5N1) viruses using a pyrosequencing method.
Topics: Amantadine; Animals; Antiviral Agents; Birds; Drug Resistance, Viral; Genetic Markers; Humans; Influenza A Virus, H5N1 Subtype; Influenza in Birds; Influenza, Human; Neuraminidase; Oseltamivir; Reverse Transcriptase Polymerase Chain Reaction; Rimantadine; RNA, Viral; Sensitivity and Specificity; Sequence Analysis, RNA; Zanamivir | 2009 |
Development of a novel real-time reverse-transcriptase PCR method for the detection of H275Y positive influenza A H1N1 isolates.
Topics: Antiviral Agents; Drug Resistance, Viral; Humans; Influenza A Virus, H1N1 Subtype; Microbial Sensitivity Tests; Mutation, Missense; Neuraminidase; Oseltamivir; Reverse Transcriptase Polymerase Chain Reaction; Sensitivity and Specificity; Time Factors; Viral Proteins | 2009 |
Detection limit used for early warning in public health surveillance.
Topics: Chemistry Techniques, Analytical; Clinical Pharmacy Information Systems; Humans; Influenza, Human; Japan; Oseltamivir; Population Surveillance; Public Health; Sensitivity and Specificity | 2009 |
Clinical features of cases of influenza A (H1N1)v in Osaka prefecture, Japan, May 2009.
Topics: Adolescent; Adult; Antigens, Viral; Antiviral Agents; Child; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Japan; Male; Middle Aged; Oseltamivir; Reagent Kits, Diagnostic; Reverse Transcriptase Polymerase Chain Reaction; Schools; Sensitivity and Specificity; Treatment Outcome; Young Adult; Zanamivir | 2009 |
Evaluation of a rapid molecular algorithm for detection of pandemic influenza A (H1N1) 2009 virus and screening for a key oseltamivir resistance (H275Y) substitution in neuraminidase.
Topics: Algorithms; Antiviral Agents; Disease Outbreaks; Drug Resistance, Viral; Hemagglutinin Glycoproteins, Influenza Virus; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Linear Models; Neuraminidase; Oseltamivir; Point Mutation; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; Sensitivity and Specificity; Viral Proteins | 2010 |
Detection of molecular markers of drug resistance in 2009 pandemic influenza A (H1N1) viruses by pyrosequencing.
Topics: Amino Acid Sequence; Antiviral Agents; Drug Resistance, Viral; Genetic Markers; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Molecular Sequence Data; Neuraminidase; Oseltamivir; Reverse Transcriptase Polymerase Chain Reaction; Sensitivity and Specificity; Sequence Analysis, DNA; Viral Matrix Proteins; Viral Proteins | 2010 |
Detection of pandemic (H1N1) 2009 virus in patients treated with oseltamivir.
Topics: Adult; Antiviral Agents; Disease Outbreaks; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Mexico; Oseltamivir; Reagent Kits, Diagnostic; Reverse Transcriptase Polymerase Chain Reaction; Sensitivity and Specificity | 2010 |
[Pandemic influenza one year after the first wave: what did we learn?].
Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Child, Preschool; Chile; Disease Outbreaks; Fluorescent Antibody Technique; Humans; Infant; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Middle Aged; Oseltamivir; Polymerase Chain Reaction; Risk Factors; Sensitivity and Specificity | 2010 |
Allele-specific conventional reverse-transcription polymerase chain reaction as a screening assay for discriminating influenza a H1N1 (H275Y) oseltamivir-resistant and wild-type viruses.
Topics: Amino Acid Substitution; Antiviral Agents; Drug Resistance, Viral; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Mass Screening; Molecular Sequence Data; Nasopharynx; Neuraminidase; Oseltamivir; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; Sensitivity and Specificity; Sequence Analysis, DNA; Viral Proteins; Virology | 2010 |
Highly sensitive and quantitative detection of the H274Y oseltamivir resistance mutation in seasonal A/H1N1 influenza virus.
Topics: Amino Acid Substitution; Drug Resistance, Viral; Europe; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Microbial Sensitivity Tests; Mutation, Missense; Neuraminidase; Oseltamivir; Reverse Transcriptase Polymerase Chain Reaction; Sensitivity and Specificity; Viral Proteins | 2010 |
Diagnostic accuracy of an allele-specific reverse transcriptase-PCR assay targeting the H275Y oseltamivir resistant mutation in 2009 pandemic influenza A/H1N1 virus.
Topics: Alleles; Antiviral Agents; DNA Primers; Drug Resistance, Viral; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Mutation; Oseltamivir; Pandemics; Reverse Transcriptase Polymerase Chain Reaction; Sensitivity and Specificity | 2010 |
Development and validation of a high-throughput and robust LC-MS/MS with electrospray ionization method for simultaneous quantitation of oseltamivir phosphate and its oseltamivir carboxylate metabolite in human plasma for pharmacokinetic studies.
Topics: Chromatography, Liquid; Drug Stability; Humans; Least-Squares Analysis; Oseltamivir; Phosphates; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2011 |
The validation of a real-time RT-PCR assay which detects influenza A and types simultaneously for influenza A H1N1 (2009) and oseltamivir-resistant (H275Y) influenza A H1N1 (2009).
Topics: Amino Acid Substitution; Drug Resistance, Viral; Humans; Influenza A virus; Influenza, Human; Microbial Sensitivity Tests; Mutation, Missense; Neuraminidase; Oseltamivir; Reverse Transcriptase Polymerase Chain Reaction; Sensitivity and Specificity; Viral Proteins | 2011 |
Feasibility of diagnosing influenza within 24 hours of symptom onset in children 1-3 years of age.
Topics: Antigens, Viral; Antiviral Agents; Child, Preschool; Early Diagnosis; Feasibility Studies; Fluoroimmunoassay; Humans; Infant; Influenza A virus; Influenza B virus; Influenza, Human; Oseltamivir; Point-of-Care Systems; Polymerase Chain Reaction; Reagent Kits, Diagnostic; Sensitivity and Specificity; Zanamivir | 2011 |
Identification of oseltamivir resistance among pandemic and seasonal influenza A (H1N1) viruses by an His275Tyr genotyping assay using the cycling probe method.
Topics: Amino Acid Substitution; Antiviral Agents; Genotype; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Microbial Sensitivity Tests; Molecular Typing; Neuraminidase; Oseltamivir; Polymorphism, Single Nucleotide; Sensitivity and Specificity; Viral Proteins | 2011 |
Development of a real-time RT-PCR assay for detection of resistance to oseltamivir in influenza A pandemic (H1N1) 2009 virus using single nucleotide polymorphism probes.
Topics: Amino Acid Substitution; Antiviral Agents; Drug Resistance, Viral; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Microbial Sensitivity Tests; Mutation, Missense; Oseltamivir; Polymorphism, Single Nucleotide; Reverse Transcriptase Polymerase Chain Reaction; Sensitivity and Specificity | 2011 |
A comparison of pyrosequencing and neuraminidase inhibition assays for the detection of oseltamivir-resistant pandemic influenza A(H1N1) 2009 viruses.
Topics: Amino Acid Substitution; Antiviral Agents; Humans; Influenza A Virus, H1N1 Subtype; Inhibitory Concentration 50; Microbial Sensitivity Tests; Mutation, Missense; Neuraminidase; Oseltamivir; Sensitivity and Specificity; Sequence Analysis, DNA; Viral Proteins | 2011 |
Ultrasensitive detection of drug-resistant pandemic 2009 (H1N1) influenza A virus by rare-variant-sensitive high-resolution melting-curve analysis.
Topics: Antiviral Agents; Drug Resistance, Viral; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Microbial Sensitivity Tests; Mutation, Missense; Oseltamivir; RNA, Viral; Sensitivity and Specificity; Transition Temperature | 2011 |
Detection of oseltamivir sensitive/resistant strains of pandemic influenza A virus (H1N1) from patients admitted to hospitals in Thailand.
Topics: Adolescent; Adult; Base Sequence; Child; Drug Resistance, Viral; Female; Hospitalization; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Limit of Detection; Male; Molecular Sequence Data; Mutagenesis, Site-Directed; Oseltamivir; Pandemics; Reverse Transcriptase Polymerase Chain Reaction; Sensitivity and Specificity; Thailand; Treatment Outcome | 2011 |
High-resolution melting approach to efficient identification and quantification of H275Y mutant influenza H1N1/2009 virus in mixed-virus-population samples.
Topics: Antiviral Agents; Coinfection; Drug Resistance, Viral; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Mutant Proteins; Mutation, Missense; Neuraminidase; Oseltamivir; Sensitivity and Specificity; Transition Temperature; Viral Load; Viral Proteins | 2011 |
Reverse-transcription polymerase chain reaction/pyrosequencing to characterize neuraminidase H275 residue of influenza A 2009 H1N1 virus for rapid and specific detection of the viral oseltamivir resistance marker in a clinical laboratory.
Topics: Adult; Antiviral Agents; Drug Resistance, Viral; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Microbial Sensitivity Tests; Mutation, Missense; Neuraminidase; Oseltamivir; Reverse Transcriptase Polymerase Chain Reaction; Sensitivity and Specificity; Sequence Analysis, DNA; Viral Proteins | 2011 |
Oseltamivir overuse at a Chicago hospital during the 2009 influenza pandemic and the poor predictive value of influenza-like illness criteria.
Topics: Adolescent; Adult; Antiviral Agents; Chicago; Child; Female; Humans; Inappropriate Prescribing; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Odds Ratio; Oseltamivir; Pandemics; Predictive Value of Tests; Risk Factors; Sensitivity and Specificity; Statistics, Nonparametric | 2012 |
[Establishment of drug screening assay and pharmacodynamic evaluation method targeting influenza RNA polymerase].
Topics: Alphainfluenzavirus; Amantadine; Antiviral Agents; Drug Evaluation, Preclinical; Genes, Reporter; HEK293 Cells; Humans; Luciferases; Oseltamivir; Plasmids; Reproducibility of Results; Ribavirin; RNA-Dependent RNA Polymerase; Sensitivity and Specificity; Transfection; Zanamivir | 2012 |
Economic analysis of influenza vaccination and antiviral treatment for healthy working adults.
Topics: Acetamides; Adolescent; Adult; Antiviral Agents; Computer Simulation; Cost of Illness; Cost-Benefit Analysis; Decision Trees; Drug Costs; Guanidines; Humans; Influenza Vaccines; Influenza, Human; Middle Aged; Oseltamivir; Pyrans; Rimantadine; Sensitivity and Specificity; Sialic Acids; Vaccination; Zanamivir | 2002 |
Management of influenza in adults older than 65 years of age: cost-effectiveness of rapid testing and antiviral therapy.
Topics: Acetamides; Aged; Amantadine; Antiviral Agents; Computer Simulation; Cost-Benefit Analysis; Decision Support Techniques; Guanidines; Humans; Influenza, Human; Oseltamivir; Pyrans; Quality-Adjusted Life Years; Rimantadine; Sensitivity and Specificity; Sialic Acids; Zanamivir | 2003 |
Summaries for patients. Cost-effective management of flu in adults older than 65 years of age.
Topics: Acetamides; Aged; Amantadine; Antiviral Agents; Computer Simulation; Cost-Benefit Analysis; Decision Support Techniques; Guanidines; Humans; Influenza, Human; Oseltamivir; Pyrans; Quality-Adjusted Life Years; Rimantadine; Sensitivity and Specificity; Sialic Acids; Zanamivir | 2003 |
Detection and control of influenza outbreaks in well-vaccinated nursing home populations.
Topics: Acetamides; Aged; Antiviral Agents; Diagnostic Techniques and Procedures; Disease Outbreaks; Homes for the Aged; Humans; Immunization Programs; Influenza A virus; Influenza B virus; Influenza, Human; Michigan; Nursing Homes; Observation; Oseltamivir; Population Surveillance; Seasons; Sensitivity and Specificity | 2004 |
H5N1 Oseltamivir-resistance detection by real-time PCR using two high sensitivity labeled TaqMan probes.
Topics: Antiviral Agents; Drug Resistance, Viral; Fluorescent Dyes; Influenza A Virus, H5N1 Subtype; Oseltamivir; Polymerase Chain Reaction; Sensitivity and Specificity | 2007 |
Effect of oseltamivir on the risk of pneumonia and use of health care services in children with clinically diagnosed influenza.
Topics: Age Distribution; Antiviral Agents; Child; Child, Preschool; Confidence Intervals; Early Diagnosis; Female; Health Services Accessibility; Hospitalization; Humans; Incidence; Infant; Influenza, Human; Male; Oseltamivir; Pneumonia, Viral; Probability; Reference Values; Registries; Retrospective Studies; Sensitivity and Specificity; Severity of Illness Index; Sex Distribution; Treatment Outcome | 2007 |
High-performance liquid chromatographic determination of GS4071, a potent inhibitor of influenza neuraminidase, in plasma by precolumn fluorescence derivatization with naphthalenedialdehyde.
Topics: Acetamides; Animals; Chromatography, High Pressure Liquid; Dogs; Enzyme Inhibitors; Ferrets; Fluorescence; Humans; Indicators and Reagents; Kinetics; Mice; Naphthalenes; Neuraminidase; Orthomyxoviridae; Oseltamivir; Potassium Cyanide; Rats; Sensitivity and Specificity; Spectrometry, Fluorescence; Temperature | 1998 |
Development of a high-performance liquid chromatographic-mass spectrometric assay for the specific and sensitive quantification of Ro 64-0802, an anti-influenza drug, and its pro-drug, oseltamivir, in human and animal plasma and urine.
Topics: Acetamides; Animals; Antiviral Agents; Chromatography, High Pressure Liquid; Humans; Influenza, Human; Mass Spectrometry; Oseltamivir; Reference Standards; Reproducibility of Results; Sensitivity and Specificity | 2000 |
Advances in pharmacology. New treatments for influenza: neuraminidase inhibitors.
Topics: Acetamides; Antiviral Agents; Drug Approval; Guanidines; Humans; Influenza, Human; Neuraminidase; Oseltamivir; Pyrans; Sensitivity and Specificity; Sialic Acids; United States; Zanamivir | 2001 |